GemPharmatech Revenue

In the year 2025, GemPharmatech had annual revenue of 793.25M CNY with 15.49% growth. GemPharmatech had revenue of 217.68M in the quarter ending December 31, 2025, with 22.90% growth.

Revenue

793.25M

Revenue Growth

+15.49%

P/S Ratio

7.83

Revenue / Employee

502.70K

Employees

1,578

Market Cap

6.21B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	793.25M	106.42M	15.49%
Dec 31, 2024	686.84M	64.65M	10.39%
Dec 31, 2023	622.19M	105.64M	20.45%
Dec 31, 2022	516.55M	122.76M	31.17%
Dec 31, 2021	393.79M	131.87M	50.35%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
R&G PharmaStudies	789.45M
Shanghai OPM Biosciences	354.91M
Xiangxue Pharmaceutical	1.47B
Beijing Konruns Pharmaceutical	871.31M
Lifecome Biochemistry	587.04M
Kexing Biopharm	1.54B
Shenzhen Weiguang Biological Products	1.14B
Novogene	2.17B

Revenue Rankings